Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 391

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics

LeWitt, Peter A.·2015·Movement Disorders

Abstract

For all its imperfections at treating Parkinson's disease (PD), orally‐administered levodopa (l‐dopa) can be regarded as the “platinum” standard of PD therapeutics for its impact on disability and discomfort and its cost‐effectiveness. The past half‐century has confirmed that the typical l‐dopa–treated patient gains improvement for most Parkinsonian features, presumably by conversion of this amino acid into dopamine in the striatum. However, fundamental questions remain as to its full mechanism of action and how adverse reactions evolve. Various aspects of clinical phenomenology associated with chronic l‐dopa use (such as dyskinesias and the long‐duration anti‐Parkinsonian response) present a continuing challenge for better understanding of its pharmacology. The pharmacokinetics of l‐dopa tend to predict some of problems that can emerge during chronic therapy, which can be linked with its irregular uptake and marked dose‐by‐dose variability in plasma concentrations. Several new pharmaceutical approaches are targeted at the unique physiology of l‐dopa uptake and are likely to improve the consistency of its anti‐Parkinsonian effect. © 2014 International Parkinson and Movement Disorder Society

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/mds.26082

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Cited by

See all 391

Metadata

Authors
LeWitt, P. A.
Venue
Movement Disorders
Publisher
Wiley
Published
2014-12
Volume
30
Issue
1
Pages
64-72
ISSN
  • 0885-3185 (ISSN-L)
  • 1531-8257
OpenAlex
W1955911053
Cited by
391
References
62
FWCI
9.31
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics. https://app.cochat.ai/papers/10.1002/mds.26082
The paper
LeWitt, P. A. (2015). Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics. Movement Disorders. https://doi.org/10.1002/mds.26082

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.